Vor Biopharma Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
/ 
Frequently asked questions
To buy Vor Biopharma Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Vor Biopharma Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Vor Biopharma Inc. is VOR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Vor Biopharma Inc. has its primary listing on NASDAQ. You can trade Vor Biopharma Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Vor Biopharma Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Vor Biopharma Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Vor Biopharma Inc..